• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期胰腺移植物失功与肾胰同期移植后晚期临床结局不良相关。

Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation.

机构信息

Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

Transplantation. 2011 Oct 15;92(7):796-801. doi: 10.1097/TP.0b013e31822dc36b.

DOI:10.1097/TP.0b013e31822dc36b
PMID:21832957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3831506/
Abstract

BACKGROUND

Early pancreas graft failure after simultaneous pancreas and kidney (SPK) transplantation is common. We studied the impact of early pancreas graft failure on long-term kidney and patient survival.

METHODS

We included all primary SPK transplants performed in the United States between January 1, 2000, and December 31, 2007, who had maintained kidney graft function at 90 days posttransplantation. Kaplan-Meier and Cox multivariate analyses were performed. The causes of death between the two cohorts were compared.

RESULTS

A total of 6282 SPK recipients were included in the analyses. Of those, 470 had lost pancreas graft within the first 90 days largely related to pancreas graft thrombosis. Early pancreas graft failure was associated with lower subsequent kidney graft and patient survival (log-rank, P=0.02 and P<0.001, respectively). Multivariate regression analyses demonstrated a 70% higher risk of kidney graft failure after 3 years (adjusted hazard ratio 1.69; 95% CI 1.08, 2.66; P=0.022) and more than doubled the risk for death (adjusted hazard ratio 2.18; 95% CI 1.67, 2.85; P<0.001) among SPK recipients with early pancreas graft failure. The causes of death were similar between the two cohorts.

CONCLUSION

Early pancreas graft failure in SPK transplant recipients is associated with an increased risk for subsequent kidney failure and death. Optimization of therapeutic interventions after early pancreas graft failure is needed.

摘要

背景

在胰肾联合移植(SPK)后,早期胰腺移植物衰竭很常见。我们研究了早期胰腺移植物衰竭对长期肾脏和患者生存的影响。

方法

我们纳入了 2000 年 1 月 1 日至 2007 年 12 月 31 日期间在美国进行的所有原发性 SPK 移植,这些患者在移植后 90 天内保持了肾脏移植物功能。进行了 Kaplan-Meier 和 Cox 多变量分析。比较了两组之间的死亡原因。

结果

共有 6282 例 SPK 受者纳入分析。其中,470 例在最初 90 天内失去了胰腺移植物,主要与胰腺移植物血栓形成有关。早期胰腺移植物衰竭与随后的肾脏移植物和患者生存率降低相关(对数秩检验,P=0.02 和 P<0.001)。多变量回归分析显示,3 年后肾脏移植物衰竭的风险增加了 70%(调整后的危险比 1.69;95%CI 1.08,2.66;P=0.022),死亡风险增加了一倍以上(调整后的危险比 2.18;95%CI 1.67,2.85;P<0.001)。两组的死亡原因相似。

结论

SPK 移植受者的早期胰腺移植物衰竭与随后发生肾衰竭和死亡的风险增加相关。需要优化早期胰腺移植物衰竭后的治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/5e67bdc7b2e5/nihms-516597-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/2817590916e4/nihms-516597-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/9b18708ee013/nihms-516597-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/5399bd5005be/nihms-516597-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/5e67bdc7b2e5/nihms-516597-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/2817590916e4/nihms-516597-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/9b18708ee013/nihms-516597-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/5399bd5005be/nihms-516597-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685c/3831506/5e67bdc7b2e5/nihms-516597-f0004.jpg

相似文献

1
Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation.早期胰腺移植物失功与肾胰同期移植后晚期临床结局不良相关。
Transplantation. 2011 Oct 15;92(7):796-801. doi: 10.1097/TP.0b013e31822dc36b.
2
Pancreas graft survival in simultaneous pancreas-kidney versus pancreas-after-kidney and pancreas alone transplantations: a single institution experience.同期胰肾联合移植与肾移植后胰腺移植及单纯胰腺移植的胰腺移植物存活情况:单中心经验
Transplant Proc. 2013;45(10):3609-11. doi: 10.1016/j.transproceed.2013.10.019.
3
Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation.胰腺移植十二个月的功能对同期胰肾联合移植后的生存率有显著影响。
Clin J Am Soc Nephrol. 2009 May;4(5):988-95. doi: 10.2215/CJN.04940908. Epub 2009 Apr 30.
4
Influence of recipient race on the outcome of simultaneous pancreas and kidney transplantation.受者种族对胰肾联合移植结局的影响。
Am J Transplant. 2010 Sep;10(9):2074-81. doi: 10.1111/j.1600-6143.2010.03211.x. Epub 2010 Jul 20.
5
Pancreas after kidney transplants.肾移植后的胰腺
Am J Surg. 2001 Aug;182(2):155-61. doi: 10.1016/s0002-9610(01)00676-6.
6
Causes of graft failure in simultaneous pancreas-kidney transplantation by various time periods.不同时间段内胰肾联合移植中移植物失败的原因。
Clin Transpl. 2013:23-30.
7
Simultaneous pancreas-kidney versus kidney-alone transplants in diabetics: increased risk of early cardiac death and acute rejection following pancreas transplants.糖尿病患者胰肾联合移植与单纯肾移植的比较:胰肾联合移植后早期心脏死亡和急性排斥反应风险增加。
Clin Transplant. 1994 Jun;8(3 Pt 1):246-51.
8
Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).向器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国胰腺移植病例的结果。
Clin Transpl. 2008:45-56.
9
A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.对胰肾联合移植与单纯肾移植生存优势的重新评估
Transplantation. 2015 Sep;99(9):1900-6. doi: 10.1097/TP.0000000000000663.
10
Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes.2 型糖尿病患者行胰肾联合移植与其他肾脏移植选择的比较。
Clin J Am Soc Nephrol. 2012 Apr;7(4):656-64. doi: 10.2215/CJN.08310811. Epub 2012 Feb 16.

引用本文的文献

1
Outcome-Orientated Organ Allocation-A Composite Risk Model for Pancreas Graft Evaluation and Acceptance.以结果为导向的器官分配——一种用于胰腺移植评估与接受的综合风险模型
J Clin Med. 2024 Aug 31;13(17):5177. doi: 10.3390/jcm13175177.
2
Favorable Outcomes in Older Recipients Receiving Simultaneous Pancreas Kidney Transplantation.老年受者接受胰肾联合移植的良好结局
Transplant Direct. 2022 Nov 17;8(12):e1413. doi: 10.1097/TXD.0000000000001413. eCollection 2022 Dec.
3
Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.1 型糖尿病患者胰肾联合移植后的生存:早期胰腺移植物功能的关键作用。
Transpl Int. 2022 Sep 12;35:10618. doi: 10.3389/ti.2022.10618. eCollection 2022.
4
Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas-Kidney Transplantation (SPKT)-A Landmark Analysis.早期胰腺移植丢失对同期胰肾联合移植(SPKT)术后结局的影响——一项里程碑式分析
J Clin Med. 2021 Jul 22;10(15):3237. doi: 10.3390/jcm10153237.
5
Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?胰肾联合移植与单纯活体供肾移植:基于结局的选择?
Curr Diab Rep. 2018 Jul 20;18(9):67. doi: 10.1007/s11892-018-1039-8.
6
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.IPITA-TTS关于β细胞替代疗法未来的意见领袖会议报告。
Transplantation. 2016 Feb;100 Suppl 2(Suppl 2):S1-44. doi: 10.1097/TP.0000000000001055.
7
Kidney Transplantation in the Diabetic Patient.糖尿病患者的肾移植
J Clin Med. 2015 Jun 9;4(6):1269-80. doi: 10.3390/jcm4061269.
8
A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.对胰肾联合移植与单纯肾移植生存优势的重新评估
Transplantation. 2015 Sep;99(9):1900-6. doi: 10.1097/TP.0000000000000663.
9
A composite risk model for predicting technical failure in pancreas transplantation.用于预测胰腺移植技术失败的综合风险模型。
Am J Transplant. 2013 Jul;13(7):1840-9. doi: 10.1111/ajt.12269. Epub 2013 May 24.
10
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease.糖尿病终末期肾病患者行胰肾联合移植后患者生存率提高。
Diabetologia. 2013 Jun;56(6):1364-71. doi: 10.1007/s00125-013-2888-y. Epub 2013 Apr 3.

本文引用的文献

1
Difference in estimated GFR with two different formulas in elderly individuals.老年个体中两种不同公式估算的肾小球滤过率的差异。
Int Urol Nephrol. 2006;38(2):381-5. doi: 10.1007/s11255-006-0065-7.
2
Efficacy and safety of benazepril for advanced chronic renal insufficiency.贝那普利治疗晚期慢性肾功能不全的疗效与安全性。
N Engl J Med. 2006 Jan 12;354(2):131-40. doi: 10.1056/NEJMoa053107.
3
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.慢性肾病中血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂:安全性问题
Semin Nephrol. 2004 Mar;24(2):168-75. doi: 10.1016/j.semnephrol.2003.11.001.
4
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.血压降低及抗高血压药物类别对高血压肾病进展的影响:AASK试验结果
JAMA. 2002 Nov 20;288(19):2421-31. doi: 10.1001/jama.288.19.2421.
5
Hyperkalemia: An adaptive response in chronic renal insufficiency.高钾血症:慢性肾功能不全中的一种适应性反应。
Kidney Int. 2002 Jul;62(1):1-9. doi: 10.1046/j.1523-1755.2002.00350.x.
6
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.血管紧张素转换酶抑制剂与非糖尿病肾病的进展。患者水平数据的荟萃分析。
Ann Intern Med. 2001 Jul 17;135(2):73-87. doi: 10.7326/0003-4819-135-2-200107170-00007.
7
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.雷米普利与氨氯地平对高血压性肾硬化症肾脏结局的影响:一项随机对照试验。
JAMA. 2001 Jun 6;285(21):2719-28. doi: 10.1001/jama.285.21.2719.
8
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂:对肾衰竭患者血钾的影响。VAL-K研究组
Kidney Int. 2000 Nov;58(5):2084-92. doi: 10.1111/j.1523-1755.2000.00381.x.
9
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?血管紧张素转换酶抑制剂相关的血清肌酐升高:这需要引起关注吗?
Arch Intern Med. 2000 Mar 13;160(5):685-93. doi: 10.1001/archinte.160.5.685.
10
A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium.低剂量的雷米普利降压器可降低尿蛋白排泄,而不会增加血钾水平。
Am J Kidney Dis. 1999 Mar;33(3):450-7. doi: 10.1016/s0272-6386(99)70181-2.